SMi Systems
Home Our Technology Biomedical Research Diagnosis Team Investors News Publications Careers Contact
HomeOur TechnologyBiomedical Research DiagnosisTeamInvestorsNewsPublicationsCareersContact
SMi Systems
SMi drives commercialisation and growth by appointing Stefan Hamill as VP of Strategy

Top-ranked life sciences analyst joins as SMi enters commercialisation with an instrument ready for early access customers and a focus shifting to precision engineered consumables.


VIEW PDF
Lucy Eccleston9 July 20242024
Facebook0 Twitter 0 Likes
Previous

SMi highlights the importance of advanced algorithms to detect and analyse single molecules

Lucy Eccleston31 July 2024Home News Block, 2024
Next

SMi discusses how single molecule imaging could impact drug development

Lucy Eccleston10 June 2024Home News Block, 2024
 

About Us
About SMi
Meet the Team
Careers
Investors
Publications
News
Contact Us

Technology & Sectors
Our Technology
Biomedical Research
Diagnosis

 

Policies & Information
Privacy Policy
Terms of Use
Company Information
Recruitment Privacy Policy

SMi Drug Discovery
Company Registration No.: 11175710
VAT No.: 332498687
Trading as SMi Systems

© 2024 SMi Drug Discovery Limited